Specifically, our results could lend credence to further therapeutical approach, i.e., human immunoglobulin monoclonal antibody directed against the human pro-inflammatory cytokine IL-15 that is associated with a variety of autoimmune and inflammatory disorders, as for some aspects, atherosclerosis could be rethought (55). The gene discussed is IL15; the disease is atherosclerosis.